Skip to content

DR SCHROVEN SHARI

Active Private limited companyfounded 2022active for 4 yearsVredestraat 195, 2550 KontichKBO/BCE: BE 0782.529.880

Lifetime

4 annual accounts with figures on one time axis
peak of €100,878 in 2025
€100,878▲ 25.6%
peak of €72,444 in 2025
€72,444▲ 21.0%
peak of €183,855 in 2024
€39,714▼ 78.4%
€78,261▲ 36×
Board1 name since 2022
1 director
Documentsfilings and deeds
10-08-202610 days late
2025micro format
Gross margin from €80,345 to €100,878Dividend €216,585Equity from €183,855 to €39,714Debts from €2,177 to €78,261Investments €11,258Cash from €96,691 to €1,310

Key points

from the 2025 annual accounts

Equity

€39,714 from €183,855 in 2024

Equity fell by 78% in 1 year.

Turnover

≈ €250,000 estimated

The micro format states no turnover.

Debts

€78,261 ▲ 36×
Other debts
+52,198
Taxes and wages
+19,127
The rest
+4,758

Debts rose by €76,083 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Investments

€11,258 2.1 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Liquidity

1.28 was 77.13 in 2024

Short-term debts rose from €2,177 to €73,081.

Filings

4 annual accounts 1 late
AprilJune31 JulyOctober2022202320242025

The 2025 accounts came 10 days late. The other three were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as DR SCHROVEN SHARI has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for DR SCHROVEN SHARI. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 22-02-2022
  • founderdeed of 25-02-2022
Board & ownership

Recent changes

Incorporation Founding capital of €5,000, 500 shares · Founded by · appointed as director · published on 25-02-2022 · Gazette deed
First establishment Vredestraat 195, Kontich
All 11 events

Official details

Source: KBO
Status
Active since 23-02-2022Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 3 activities
Establishment unit
2.344.178.5112550 Kontich, since 23-02-2022
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

€117,974▼ 36.6%
Filing
Filed on 10-08-2026
Financials

Insights on DR SCHROVEN SHARI

DR SCHROVEN SHARI files the micro format. That format states no turnover. The gross margin rose from €71,999 in 2022 to €100,878 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR SCHROVEN SHARI

What is the company number of DR SCHROVEN SHARI?
The company number of DR SCHROVEN SHARI is 0782.529.880. The VAT number is the same number with BE in front: BE 0782.529.880.
Where is DR SCHROVEN SHARI based?
The registered office is at Vredestraat 195, 2550 Kontich.Company details
What does DR SCHROVEN SHARI do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of DR SCHROVEN SHARI?
DR SCHROVEN SHARI is a private limited company (BV).
When was DR SCHROVEN SHARI founded?
DR SCHROVEN SHARI was founded on 23-02-2022.
Is DR SCHROVEN SHARI still active?
Yes, DR SCHROVEN SHARI is an active enterprise in the KBO register.
What is the turnover of DR SCHROVEN SHARI?
The turnover in financial year 2025 is about €250,000. This figure is estimated from the gross margin of €100,878 and 2,451 comparable companies of the same size. It probably lies between €170,000 and €390,000. It is a rough estimate.Financials
Is DR SCHROVEN SHARI profitable?
In financial year 2025, DR SCHROVEN SHARI made a profit of €72,444.
Where can I find the annual accounts of DR SCHROVEN SHARI?
DR SCHROVEN SHARI filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR SCHROVEN SHARI due?
DR SCHROVEN SHARI must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.